EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
about
Epithelial-mesenchymal transition in gastric cancerContactin 1: A potential therapeutic target and biomarker in gastric cancerTargeting the Eph System with Peptides and Peptide ConjugatesWnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesisTankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals.Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewCrucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.Role of epithelial-mesenchymal transition in gastric cancer initiation and progressionmiR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro.Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer.CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signalingWnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progressionGlutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185Eph receptor and ephrin function in breast, gut, and skin epithelia.miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT.Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.EphA2 silencing promotes growth, migration, and metastasis in salivary adenoid cystic carcinoma: in vitro and in vivo studyAquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival.EphA2 is a functional receptor for the growth factor progranulin.Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells.Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancerGOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancerThe role of EPH receptors in cancer-related epithelial-mesenchymal transitionThe double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer.EphA3 biology and cancer.Eph family co-expression patterns define unique clusters predictive of cancer phenotype.EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.
P2860
Q26775029-5350897B-8901-487A-B8F6-CD6C61E09AB2Q26781524-2F947993-3744-4108-97C6-6C237ECF8C72Q26799461-78B3AEB8-134A-4E8A-9B85-AFD8133BDC1EQ26825046-5AF3EA3A-9CC0-4874-ACF6-DA0281667199Q27305064-E36B7A4E-4672-47C8-9C48-CAF87B5462D4Q28086989-C6B2B46D-38AF-4754-ADE0-786C368AFFC6Q28115187-7BBCD682-EDF0-49A9-AA46-B46535767227Q30384677-3E2B532F-3226-484A-A3A3-B0A83514E04CQ31090776-468944AD-A477-4A77-BA2C-D959864C52CDQ33594912-2ABBE22C-2D98-46E9-A941-C2592AAD2E83Q33599027-4DB3BD59-1519-4DDD-BE8F-18585EB14671Q33676514-6375E217-1207-4923-B8B8-471B742CA422Q33711342-73070CB7-9CC0-46F9-9F6F-ED3381B23F19Q33894926-99F51EEA-8C77-48C8-8A43-51D1CD08AB08Q34501883-19BACF5A-491B-443D-9DAA-4F8A76BC28FCQ34728041-6EDC7EA0-636E-4C3B-8B95-2A9C3DBCABB4Q35049866-6166CC64-4483-4C5A-AB5D-4F64D42E66E3Q35854054-D774B8C4-2D02-4940-BC2B-256B0B9C3558Q36125059-40ACDB7F-ACC3-4139-AA5F-1328CCE366E1Q36222725-259C757D-680A-40D8-BD44-E86A6CF6A2D3Q36241000-0D0BAABE-82CC-431E-8753-17FC90331D22Q36277354-E1D7B623-19CD-43E7-9FC1-A0DDEFBB86C7Q36545991-32D811C8-6E8C-4305-9149-AA55501ED74DQ36580880-255251E4-3E53-4627-A534-FF39B8A54A47Q36602338-A874E2AF-48E0-4B8F-9094-18790FC8374EQ36878606-4FA9E19A-86FA-438F-9F55-F4CFE861D42EQ37086074-A5AAAE1C-F432-4FA2-B1BE-75CAF722D4D4Q37295470-1806A839-328E-4059-8435-71372436E404Q37452286-ABD02160-98B5-456B-9D75-043A7C2CD7BBQ37488302-018E3A71-831C-43F1-ADB4-64E0B9C73051Q37609400-97080E17-A6C4-4771-9633-8D291E4DF365Q37699354-0AD2F7E5-4360-4FC7-94E3-10492274B8C4Q37717749-4882BFFE-7893-4076-82DB-2679CEAC915FQ37747417-ED51D86C-C218-424A-A279-FEA60375BE84Q38150596-5BCE069A-CB1C-4378-933A-C6319228F4E0Q38210012-4040C6E3-A951-4019-BFEA-758D8E0C3E6DQ38267753-48A96BF3-483E-4D03-9E5B-3FA4DE02E14DQ38269791-1F2D4349-4DAA-44B0-9C59-7B9C196AA0ACQ38699981-6EC41828-D8D6-4D2E-9449-52B94B66BCC1Q38725781-42527FED-ACE9-49E5-9832-8C2D70607F2A
P2860
EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@en
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@nl
type
label
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@en
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@nl
prefLabel
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@en
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
EphA2 promotes epithelial-mese ...... thway in gastric cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.238
P407
P577
2013-06-10T00:00:00Z
P6179
1040864164